Someone who has been on several medications for a lengthy period of time without any improvement in their depression may be a good candidate to get started on Spravato®. Spravato® is the first nasal spray medication that is a treatment for Major Depressive Disorder (MDD) and Treatment-Resistant Depression (TRD). Spravato® is FDA-approved to treat depression in combination with an oral antidepressant.
Before prescribing Spravato® to you, your healthcare provider will review your medical history and discuss potential side effects and interactions. If it is determined that Spravato® is the right treatment plan for you, your treatment plan can be mapped out and your appointments can then be scheduled.
© 2023 Dayton Behavioral Care. All Rights Reserved.
